ANIK
Price:
$24.56
Market Cap:
$363.41M
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management product family consists of Monovisc, Orthovisc, Cingal, and Hyvisc that are indicated to provide pain relief from osteoarthritis conditions; and joint preservation and restoration product family comprise a portfolio of approximately 150 bone prese...[Read more]
Industry
Medical - Devices
IPO Date
1993-05-03
Stock Exchange
NASDAQ
Ticker
ANIK
According to Anika Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -4.85. This represents a change of -98.27% compared to the average of -280.59 of the last 4 quarters.
The mean historical PE Ratio of Anika Therapeutics, Inc. over the last ten years is 19.87. The current -4.85 PE Ratio has changed -2540.64% with respect to the historical average. Over the past ten years (40 quarters), ANIK's PE Ratio was at its highest in in the September 2021 quarter at 275.13. The PE Ratio was at its lowest in in the June 2024 quarter at -1089.74.
Average
19.87
Median
20.31
Minimum
-29.01
Maximum
124.82
Discovering the peaks and valleys of Anika Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 19.20%
Maximum Annual PE Ratio = 124.82
Minimum Annual Increase = -565.02%
Minimum Annual PE Ratio = -29.01
Year | PE Ratio | Change |
---|---|---|
2023 | -4.02 | -86.15% |
2022 | -29.01 | -123.24% |
2021 | 124.82 | -565.02% |
2020 | -26.84 | -199.69% |
2019 | 26.93 | 3.85% |
2018 | 25.93 | 4.98% |
2017 | 24.70 | 11.82% |
2016 | 22.09 | 19.20% |
2015 | 18.53 | 18.73% |
2014 | 15.61 | -40.27% |
The current PE Ratio of Anika Therapeutics, Inc. (ANIK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
30.60
5-year avg
18.38
10-year avg
19.87
Anika Therapeutics, Inc.’s PE Ratio is greater than AxoGen, Inc. (-34.41), greater than Orthofix Medical Inc. (-5.12), greater than Surmodics, Inc. (-393.30), greater than Paragon 28, Inc. (-10.66), greater than Artivion, Inc. (-125.20), greater than Sight Sciences, Inc. (-6.06), less than Avanos Medical, Inc. (141.40), greater than OrthoPediatrics Corp. (-28.25), greater than NeuroPace, Inc. (-6.95), less than CVRx, Inc. (-3.35), less than ProSomnus, Inc. Common Stock (-0.59), greater than Heska Corporation (-91.49),
Company | PE Ratio | Market cap |
---|---|---|
-34.41 | $570.66M | |
-5.12 | $619.96M | |
-393.30 | $553.99M | |
-10.66 | $609.86M | |
-125.20 | $1.05B | |
-6.06 | $319.45M | |
141.40 | $1.09B | |
-28.25 | $742.41M | |
-6.95 | $210.22M | |
-3.35 | $183.44M | |
-0.59 | $8.18M | |
-91.49 | $1.31B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Anika Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Anika Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Anika Therapeutics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Anika Therapeutics, Inc. (ANIK)?
What is the highest PE Ratio for Anika Therapeutics, Inc. (ANIK)?
What is the 3-year average PE Ratio for Anika Therapeutics, Inc. (ANIK)?
What is the 5-year average PE Ratio for Anika Therapeutics, Inc. (ANIK)?
How does the current PE Ratio for Anika Therapeutics, Inc. (ANIK) compare to its historical average?